Acute lymphoblastic leukemia and the lymphoblastic lymphomas of childhood.
Recent advances in diagnosis, treatment, and tumor biology of the lymphoid blastic malignancies have challenged historical concepts and created a need for revised classification of these diseases. The authors review this material and present a classification relevant to current therapeutic protocols and available biological data. Further advances in understanding of these diseases can be anticipated, with possible further evolution of classification. The exact clinical role of sensitive studies to monitor residual disease during and after treatment remains to be established. These diseases may present difficult differential diagnostic problems. The importance of accurate diagnosis cannot be overemphasized, as highly successful but divergent treatments have evolved for these various hematopoietic diseases. Diagnostic problems are usually resolved with systematic analysis including careful morphology, cytochemistry, immunologic analysis, and addition of EM and other studies in selected circumstances.
Head
D R
DR
Department of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN 38101-0318, USA.
Behm
F G
FG
D001853:Bone Marrow / Q000473:pathology; D002648:Child; D003581:Cytodiagnosis; D003937:Diagnosis, Differential; D006651:Histocytochemistry; D006801:Humans; D016130:Immunophenotyping; D017254:Leukemic Infiltration; D008198:Lymph Nodes / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology